Congenital diaphragmatic hernia: Endothelin-1, pulmonary hypertension, and disease severity

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 4, 2010, Pages 555-561

  Keller, Roberta L ^a   Tacy, Theresa A ^a   Hendricks Munoz, Karen ^c   Xu, Jie ^c   Moon Grady, Anita J ^a   Neuhaus, John ^a   Moore, Phillip ^a   Nobuhara, Kerilyn K ^a   Hawgood, Sam ^a,b   Fineman, Jeffrey R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Biological markers; Bronchopulmonary dysplasia; Echocardiography

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; BIOLOGICAL MARKER;

AMBIENT AIR; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONGENITAL DIAPHRAGM HERNIA; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYPOTHESIS; INFANT; LUNG ARTERY PRESSURE; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; BLOOD; DIAPHRAGM HERNIA; HOSPITALIZATION; METHODOLOGY; NEWBORN; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL;

BIOLOGICAL MARKERS; COHORT STUDIES; ECHOCARDIOGRAPHY; ENDOTHELIN-1; FEMALE; HERNIA, DIAPHRAGMATIC; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 77957068306     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200907-1126OC     Document Type: Article

References (64)

1. Stege G, Fenton A, Jaffray B. Nihilism in the 1990s: the true mortality of congenital diaphragmatic hernia. Pediatrics 2003;112:532-535. (Pubitemid 37082102)
2. Colvin J, Bower C, Dickinson JE, Sokol J. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia. Pediatrics 2005;116:e356-e363.
3. Gallot D, Boda C, Ughetto S, Perthus I, Robert-Gnansia E, Francannet C, Laurichesse-Delmas H, Jani J, Coste K, Deprest J, et al. Prenatal detection and outcome of congenital diaphragmatic hernia: a French registry-based study. Ultrasound Obstet Gynecol 2007;29:276-283.
4. Kitigawa M, Hislop A, Boyden EA, Reid L. Lung hypoplasia in congenital diaphragmatic hernia. Br J Surg 1971;58:342-346.
5. Naeye RL, Shochat SJ, Whitman V, Maisels MJ. Unsuspected pulmonary vascular abnormalities associated with diaphragmatic hernia. Pediatrics 1976;58:902-906.
6. Geggel RL, Murphy JD, Langleban D, Crone RK, Vacanti JP, Reid LM. Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. J Pediatr 1985;107:457-464. (Pubitemid 15240809)
7. Muratore C, Utter S, Jaksic T, Lund D, Wilson J. Nutritional morbidity in survivors of congenital diaphragmatic hernia. J Pediatr Surg 2001;36:1171-1176.
8. Cortes RA, Keller RL, Townsend T, Harrison MR, Farmer DL, Lee H, Piecuch RE, Leonard CH, Hetherton M, Bisgaard R, et al. Survival of severe congenital diaphragmatic hernia has morbid consequences. J Pediatr Surg 2005;I40:36-46.
9. Chiu PPL, Sauer C, Mihailovic A, Adatia I, Bohn D, Coates AL, Langer JC. The price of success in the management of congenital diaphragmatic hernia: is improved survival accompanied by an increase in long-term morbidity? J Pediatr Surg 2006;41:888-892.
10. Bos AP, Tibboel D, Koot VCM, Hazebroek FWJ, Molenaar JC. Persistent pulmonary hypertension in high-risk congenital diaphragmatic hernia patients: incidence and vasodilator therapy. J Pediatr Surg 1993;28:1463-1465.
11. Dillon PW, Cilley RE, Mauger D, Zachary C, Meier A. The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia. J Pediatr Surg 2004;39:307-312.
12. Thibeault DW, Haney B. Lung volume, pulmonary vasculature, and factors affecting survival in congenital diaphragmatic hernia. Pediatrics 1998;101:289-295. (Pubitemid 28076666)
13. Bland RD, Albertine KH, Carlton DP, MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 2005;172:899-906.
14. Fratz S, Meyrick B, Ovadia B, Johengen MJ, Reinhartz O, Azakie A, Ross G, Fitzgerald R, Oishi P, Hess J, et al. Chronic endothelin A receptor blockade in lambs with increased pulmonary blood flow and pressure. Am J Physiol Lung Cell Mol Physiol 2004;287:L592-L597.
15. Storme L, Parker TA, Kinsella JP, Rairigh RL, Abman SH. Chronic hypertension impairs flow-induced vasodilation and augments the myogenic response in fetal lung. Am J Physiol Lung Cell Mol Physiol 2002;282:L56-L66.
16. Fineman JR, Wong J, Morin FC, Wild LM, Soifer SJ. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest 1994;93:2675-2683.
17. Christou H, Adatia I, Van Marter LJ, Kane JW, Thompson JE, Stark AR, Wessel DL, Kourembanas S. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 59-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr 1997;130:603-611.
18. Ladha F, Bonnet S, Michelakis ED, Eaton F, Hashimoto K, Archer SL, Thebaud B. Sildenafil decreases pulmonary hypertension and improves alveolarization in experimental hyperoxia-induced BPD in newborn rats [abstract]. Pediatr Res 2004;55:436A.
19. Lin YJ, Markham NE, Balasubramaniam V, Tang JR, Maxey A, Kinsella JP, Abman SH. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 2005;58:22-29.
20. McGrath-Morrow SA, Cho C, Cho C, Zhen L, Hicklin DJ, Tuder RM. Vascular endothelial growth factor receptor 2 blockade disrupts postnatal lung development. Am J Respir Cell Mol Biol 2005;32:420-427.
21. Tang J, Markham N, Lin Y, McMurty I, Maxey A, Kinsella J, Abman S. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 2004;287:L344-L351.
22. Todd L, Mullen M, Olley PM, Rabinovitch M. Pulmonary toxicity of monocrotaline differs at critical periods of lung development. Pediatr Res 1985;19:731-737. (Pubitemid 15006493)
23. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
24. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, Temma S, Shirakami G, Imura H, Mikawa H. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects: evidence for increased production of endothelin in pulmonary circulation. Circulation 1991;84:2280-2285.
25. Tutar HE, Imamoglu A, Atalay S, Gumus H, Akar N. Plasma endothelin-1 levels in patients with left-to-right shunt with or without pulmonary hypertension. Int J Cardiol 1999;70:57-62.
26. Dupuis J, Cernacek P, Tardif JC, Stewart DJ, Gosselin G, Dyrda I, Bonan R, Crepeau J. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J 1998;135:614-620.
27. Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, Hoeffken G. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 2001;120:1562-1569.
28. Staniloae C, Dupuis J, White M, Gosselin G, Dyrda I, Bois M, Crepeau J, Bonan R, Caron A, Lavoie J. Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension. J Card Fail 2004;10:427-432.
29. Langleban D, Dupuis J, Hirsch A, Giovinazzo M, Langleban I, Khoury J, Ruel N, Caron A. Pulmonary endothelin-1 clearance in human pulmonary arterial hypertension. Chest 2005;128:622S.
30. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfiels B, Abman SH. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1993;123:109-114.
31. Kobayashi H, Puri P. Plasma endothelin levels in congenital diaphragmatic hernia. J Pediatr Surg 1994;29:1258-1261. (Pubitemid 24299597)
32. de Lagausie P, de Buys-Roessingh A, Ferdadji L, Saada J, Aisenfisz S, Martinez-Vinson C, Fund X, Cayuela JM, Peuchmaur M, Mercier JC, et al. Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J Pathol 2005;205:112-118.
33. Kavanagh M, Battistini B, Kluth D, Jean S, Fournier L, Yeng AY, Major D, Cloutier R. Effect of CGS 26303, an endothelin-converting enzyme-neutral endopeptidase inhibitor, on nitrofen-induced congenital diaphragmatic hernia in the rat. J Pediatr Surg 2000;35:780-784.
34. B-receptor stimulation in experimental congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol 2000;278:L923-L932.
35. A receptor antagonist, on the cardiopulmonary profile of newborn lambs with surgically-induced diaphragmatic hernia. Br J Pharmacol 2001;134:1679-1688.
36. Kavanagh M, Seaborn T, Crochetiere J, Fournier L, Battistini B, Piedboeuf B, Major D. Modulating effect of a selective endothelin A receptor antagonist on pulmonary endothelin system protein expression in experimental diaphragmatic hernia. J Pediatr Surg 2005;40:1382-1389.
37. Keller RL, Tacy T, Xu J, Hendricks-Munoz K, Hawgood S, Fineman J. Elevated plasma endothelin-1 (ET1) levels are associated with death in newborns with congenital diaphragmatic hernia (CDH). E-PAS 2006;59:5560.349.
38. Keller RL, Hawgood S, Neuhaus JM, Farmer DL, Lee H, Albanese CT, Harrison MR, Kitterman JA. Infant pulmonary function in a randomized trial of fetal tracheal occlusion for severe congenital diaphragmatic hernia. Pediatr Res 2004;56:818-825. (Pubitemid 39403411)
39. Wong J, Reddy VM, Hendricks-Munoz K, Liddicoat JR, Gerrets R, Fineman JR. Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol 1995;269:H1965-H1972.
40. Musewe NN, Smallhorn JF, Benson LN, Burrows PE, Freedom RM. Validation of Doppler-derived pulmonary arterial pressure on patients with ductus arteriosus under different hemodynamic states. Circulation 1987;76:1081-1091.
41. Reisner SA, Azzam Z, Halmann M, Rinkevich D, Siderman S, Markiewicz W, Beyar R. Septal/free wall curvature ratio: a noninvasive index of pulmonary arterial pressure. J Am Soc Echocardiogr 1994;7:27-35.
42. Dong SJ, Smith ER, Tyberg JV. Changes in the radius of curvature of the ventricular septum at end diastole during pulmonary arterial and aortic constrictions in the dog. Circulation 1992;86:1280-1290.
43. Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008;121:317-325. (Pubitemid 351198454)
44. Okuyama H, Kubota A, Kawahara H, Oue T, Kitayama Y, Yagi M. Correlation between lung scintigraphy and long-term outcome in survivors of congenital diaphragmatic hernia. Pediatr Pulmonol 2006;41:882-886.
45. Nagaya M, Akatsuka H, Kato J, Niimi N, Ishiguro Y. Development in lung function of the affected side after repair of congenital diaphragmatic hernia. J Pediatr Surg 1996;31:349-356.
46. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732-1739. (Pubitemid 23170122)
47. Druml W, Steltzer H, Waldhausl W, Lenz K, Hammerle A, Vierhapper H, Gasic S, Wagner OF. Endothelin-1 in adult respiratory distress syndrome. Am Rev Respir Dis 1993;148:1169-1173.
48. Langleban D, DeMarchi M, Laporta D, Spanier AH, Schlesinger RD, Stewart DJ. Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Respir Dis 1993;148:1646-1650. (Pubitemid 2024137)
49. Reesink HJ, Meijer RC, Lutter R, Boomsma F, Jansen HM, Kloek JJ, Bresser P. Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Circ J 2006;70:1058-1063.
50. Dupuis J, Stewart DJ, Cernacek P, Gosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 1996;94:1578-1584.
51. Langleban D, Barst RJ, Badesch D, Groves BM, Tapson VF, Murali S, Bourge RC, Ettinger N, Shalit E, Clayton LM, et al. Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. Circulation 1999;99:3266-3271.
52. Burkhardt M, Barton M, Shaw SG. Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1: differential effects of acute and chronic ETA receptor blockade. J Hypertens 2000;18:273-279.
53. Bauer M, Wilkens H, Langer F, Schneider SO, Lausberg H, Schafers HJ. Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation 2002;105:1034-1036.
54. Black SM, Mata-Greenwood E, Dettman RW, Ovadia B, Fitzgerald RK, Reinhartz O, Thelitz S, Steinhorn RH, Gerrets R, Hendricks-Munoz K, et al. Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow. Circulation 2003;108:1646-1654.
55. Migneault A, Sauvageau S, Villeneuve L, Thorin E, Fournier A, Leblanc N, Dupuis J. Chronically elevated endothelin levels reduce pulmonary vascular reactivity to nitric oxide. Am J Respir Crit Care Med 2005;171:506-513.
56. Hocher B, Schwarz A, Fagan KA, Thone-Reineke C, El-Hag K, Kusserow H, Elitok S, Bauer C, Neumayer HH, Rodman DM, et al. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Cell Mol Biol 2000;23:19-26.
57. Wedgewood S, Dettman RW, Black SM. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 2001;281:L1058-L1067.
58. Wedgewood S, Steinhorn RH, Bunderson M, Wilham J, Lakshminrusimha S, Brennan LA, Black SM. Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 2005;289:L660-L666.
59. Grobe AC, Wells SM, Benavidez E, Oishi P, Azakie A, Fineman JR, Black SM. Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. Am J Physiol Lung Cell Mol Physiol 2006;290:L1069-L1077. (Pubitemid 43830850)
60. Keller RL, Moore P, Teitel D, Hawgood S, McQuitty J, Fineman JR. Abnormal vascular tone in infants and children with lung hypoplasia: findings from cardiac catheterization and the response to therapy. Pediatr Crit Care Med 2006;7:589-594.
61. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, Thebaud B. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 2005;172:750-756.
62. McMullan DM, Bekker JM, Johengen MJ, Hendricks-Munoz K, Gerrets R, Black SM, Fineman JR. Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1. Am J Physiol Heart Circ Physiol 2001;280:H777-H785.
63. Chen L, He H, Mondejar EF, Freden F, Wiklund P, Alving K, Hedenstierna G. Endothelin-1 and nitric oxide synthase in short rebound reaction to short exposure to inhaled nitric oxide. Am J Physiol Heart Circ Physiol 2001;281:H124-H131.
64. Pearl JM, Nelson DP, Raake JL, Manning PB, Schwartz SM, Koons L, Shanley TP, Wong HR, Duffy JY. Inhaled nitric oxide increases endothelin-1 levels: a potential cause of rebound pulmonary hypertension. Crit Care Med 2002;30:89-93.